Actively managed fund

Polar Capital Biotech I Inc

ISIN
IE00B42Z4531

How good is this fund, really?

See the rating in the app

About Polar Capital Biotech I Inc

Polar Capital Funds plc's biotechnology sub-fund, Polar Capital Biotechnology, is offered here as Class I US dollar distribution shares, which may pay an annual dividend if the directors decide. The fund buys equity in biotechnology, diagnostics and life sciences tools businesses across the globe, diversified by country, sub-sector and market capitalisation, with the dual aim of preserving capital and growing it over the long term. It is actively managed and seeks to beat the NASDAQ Biotechnology Net Total Return Index (USD); a 10% performance fee applies to returns above that index, amounting to 0.86% in 2025. On top sits an ongoing charge of 1.10%. Launched on 31 October 2013, it is classified under SFDR Article 8. Risk is rated 6 of 7, and five years is the suggested minimum hold.

Watch this fund for free Add Polar Capital Biotech I Inc to your watchlist in the PowerFunds app and we tell you when it falls behind the rest of its category.

Watch the fund for free

Where to buy Polar Capital Biotech I Inc — platforms and fees

Sold on one platform we follow.

Polar Capital Biotech I Inc — its category

Sector Equity Biotechnology — PowerFunds rates 55 funds in this category every month.

Biotechnology funds →

Other funds